In a sec­ond big set­back for Covid-19 an­ti­body treat­ment hopes, Re­gen­eron halts en­roll­ment for more se­vere pa­tients

Re­gen­eron has just de­liv­ered more bad news for the hope that neu­tral­iz­ing an­ti­bod­ies could be used to treat pa­tients with more se­vere forms of Covid …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.